Table 1. Characteristics of CRC patients between PHF19 high and low cohort from the TCGA database.
| Variables | PHF19 mRNA level | P value | |
|---|---|---|---|
| High (n = 173) | Low (n = 174) | ||
| Age (median, years) | 65.2 | 62 | 0.217 |
| Gender | 0.785 | ||
| Male | 93 (53.8) | 91 (52.3) | |
| female | 80 (46.2) | 83 (47.7) | |
| Primary site | 0.975 | ||
| Colon | 132 (76.3) | 133 (76.4) | |
| Rectum | 23 (13.3) | 24 (13.8) | |
| Junction | 18 (10.4) | 17 (9.8) | |
| Race | 0.185 | ||
| White | 139 (80.3) | 131 (75.3) | |
| Black | 31 (17.9) | 34 (19.5) | |
| Other | 3 (1.7) | 9 (3.5) | |
| Histology type | 0.244 | ||
| adenomas | 148 (85.5) | 151 (86.8) | |
| Mucinous | 25 (14.5) | 23 (13.2) | |
| Stage | |||
| I | 21 (12.1) | 31 (17.8) | 0.402 |
| II | 66 (38.2) | 59 (33.9) | |
| III | 59 (34.1) | 59 (33.9) | |
| IV | 27(15.6) | 25 (14.4) | |
| AJCC T stage | 0.026 | ||
| T1 | 7 (4.0) | 5 (2.9) | |
| T2 | 17 (9.8) | 31 (17.8) | |
| T3 | 118 (68.2) | 122 (70.1) | |
| T4 | 31 (17.9) | 16 (9.2) | |
| AJCC N stage | 0.867 | ||
| N0 | 89(51.4) | 94(54.0) | |
| N1 | 51(29.5) | 50(28.7) | |
| N2 | 33(19.1) | 30(17.2) | |
| AJCC M stage | |||
| M0 | 123 (83.1) | 117 (82.4) | 0.872 |
| M1 | 25 (16.9) | 25 (17.6) | |
| CEA (median, ng/ml) | 91.1 | 40.5 | <0.001 |
| Lymph invasion | 0.495 | ||
| Yes | 52 (33.1) | 47 (29.6) | |
| No | 105 (66.9) | 112 (70.4) | |
| Vein invasion | 0.077 | ||
| Yes | 31 (20.0) | 16 (12.2) | |
| No | 124 (80.0) | 115 (87.8) | |